The 17-Gene Genomic Prostate Score Assay Is Prognostic for Biochemical Failure in Men With Localized Prostate Cancer After Radiation Therapy at a Community Cancer Center

Purpose: The objective of this study was to assess the association between the Oncotype DX Genomic Prostate Score (GPS) assay and long-term outcomes in men with localized prostate cancer (PCa) after radiation therapy (RT). We hypothesized that the GPS assay is prognostic for biochemical failure (BCF...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Daniel J. Canter, MD, Caroline Branch, MSN, NP-C, Jason Shelnutt, MBA, Aimee J. Foreman, MA, Amy M. Lehman, MAS, Varun Sama, MS, David K. Edwards, V, PhD, John Abran, MD
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Elsevier 2023-07-01
סדרה:	Advances in Radiation Oncology
גישה מקוונת:	http://www.sciencedirect.com/science/article/pii/S2452109423000222
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!